Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
anti-human interferon alpha monoclonal antibody
- Development stage
- Preclinical
- Lead developer
- Anke Bio
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
01
Overview
This anti-human interferon alpha monoclonal antibody is an investigational therapeutic candidate being developed by Anke (AnkeBio). Currently in the preclinical stage, the antibody is designed to target and neutralize human interferon-alpha (IFN-α), a type I interferon that plays a pivotal role in the innate immune response. Overproduction or dysregulation of IFN-α is a hallmark of several autoimmune conditions, most notably systemic lupus erythematosus (SLE). By binding to IFN-α and preventing its interaction with its receptor, this monoclonal antibody aims to modulate the inflammatory signaling pathways that drive disease progression in interferon-mediated pathologies.
- Other names
- Anke-IFN-α-monoclonal antibodyHuman interferon α monoclonal antibody
02
Targets
IFN-α (Interferon alpha-7)
Beyond the preview
Go deeper on anti-human interferon alpha monoclonal antibody.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on anti-human interferon alpha monoclonal antibody.